World’s First Integrated Imaging Service for Long Covid approved by UK’s MHRA. Read more.
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS)
 |
Summary Identification and validation of biomarkers for non-alcoholic steatohepatitis (NASH) and across the spectrum of non-alcoholic fatty liver disease (NAFLD). |
 |
Disease Area Liver Disease |
 |
Product LiverMultiScan® |
 |
Status Open for Recruitment |
 |
Country Multiple European |
 |
Website |